Topics:

Colorectal Cancer

Colorectal Cancer

A new study shows that people with high levels of the 15-PGDH enzyme who used aspirin regularly were half as likely to be diagnosed with colorectal cancer.

We have yet to establish a standard practice for maintenance therapy in metastatic colorectal cancer. Of course, ideally we could find a biomarker of benefit for patients who should be managed this way, but thus far we have had no such luck.

The addition of cetuximab to chemotherapy containing oxaliplatin and fluorouracil resulted in a significantly shorter progression-free survival in patients with operable KRAS exon 2 wild-type colorectal cancer liver metastases, according to results of a recent study.

The greater distance a patient had to travel to reach a diagnosing facility the more likely that patient was to present with a higher stage disease of colon cancer, according to the results of a recent study.

A new study reports that a multitarget stool DNA test is sensitive and accurate and is an improvement over previous DNA stool-based detection tests.

In this review we discuss the current treatment options in metastatic colon cancer, with a special focus on biologic agents and how molecular understanding guides treatment decisions.

Progress in the area of targeted therapies for colorectal cancer has come slowly and with some difficulty.

Pages

Subscribe to Colorectal Cancer on [sitename]

CME Center

Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.

By clicking Accept, you agree to become a member of the UBM Medica Community.